Cite
Matrix Metalloproteinase-14 Is a Negative Prognostic Marker for Patients with Gastric Cancer.
MLA
He, Liang, et al. “Matrix Metalloproteinase-14 Is a Negative Prognostic Marker for Patients with Gastric Cancer.” Digestive Diseases & Sciences, vol. 58, no. 5, May 2013, pp. 1264–70. EBSCOhost, https://doi.org/10.1007/s10620-012-2513-9.
APA
He, L., Chu, D., Li, X., Zheng, J., Liu, S., Li, J., Zhao, Q., & Ji, G. (2013). Matrix Metalloproteinase-14 Is a Negative Prognostic Marker for Patients with Gastric Cancer. Digestive Diseases & Sciences, 58(5), 1264–1270. https://doi.org/10.1007/s10620-012-2513-9
Chicago
He, Liang, Dake Chu, Xia Li, Jianyong Zheng, Shanhong Liu, Jipeng Li, Qingchuan Zhao, and Gang Ji. 2013. “Matrix Metalloproteinase-14 Is a Negative Prognostic Marker for Patients with Gastric Cancer.” Digestive Diseases & Sciences 58 (5): 1264–70. doi:10.1007/s10620-012-2513-9.